Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Midazolam 10mg/2ml oromucosal soln pf oral syringes SF
0408020W0AAADAD
|
Midazolam hydrochloride (Buccal) | Midazolam hydrochloride | Central Nervous System | 7,366 |
|
Midazolam 7.5mg/1.5ml oromucosal soln pf oral syringes SF
0408020W0AAACAC
|
Midazolam hydrochloride (Buccal) | Midazolam hydrochloride | Central Nervous System | 2,128 |
|
Midazolam 5mg/1ml oromucosal soln pf oral syringes SF
0408020W0AAABAB
|
Midazolam hydrochloride (Buccal) | Midazolam hydrochloride | Central Nervous System | 2,072 |
|
Midazolam 2.5mg/0.5ml oromucosal soln pf oral syringes SF
0408020W0AAAAAA
|
Midazolam hydrochloride (Buccal) | Midazolam hydrochloride | Central Nervous System | 490 |
|
Midazolam 2.5mg/0.25ml oromucosal soln pf oral syringes
0408020W0AAAGAG
|
Midazolam hydrochloride (Buccal) | Midazolam hydrochloride | Central Nervous System | No data available |
|
Midazolam 2mg/ml oral solution sugar free
0408020W0AAAHAH
|
Midazolam hydrochloride (Buccal) | Midazolam hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.